NO20045587L - Liposome vaccine formulation for finding fish - Google Patents

Liposome vaccine formulation for finding fish

Info

Publication number
NO20045587L
NO20045587L NO20045587A NO20045587A NO20045587L NO 20045587 L NO20045587 L NO 20045587L NO 20045587 A NO20045587 A NO 20045587A NO 20045587 A NO20045587 A NO 20045587A NO 20045587 L NO20045587 L NO 20045587L
Authority
NO
Norway
Prior art keywords
fish
vaccines
liposome
vaccine formulation
methods
Prior art date
Application number
NO20045587A
Other languages
Norwegian (no)
Other versions
NO335784B1 (en
Inventor
Christian Syvertsen
Kevin M W Keough
Original Assignee
Genesis Group Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genesis Group Inc filed Critical Genesis Group Inc
Publication of NO20045587L publication Critical patent/NO20045587L/en
Publication of NO335784B1 publication Critical patent/NO335784B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0233—Rickettsiales, e.g. Anaplasma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/107—Vibrio
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55583—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55588—Adjuvants of undefined constitution
    • A61K2039/55594—Adjuvants of undefined constitution from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0208—Specific bacteria not otherwise provided for
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/10011—Birnaviridae
    • C12N2720/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Det beskrives liposomvaksineformuleringer for fmne-fisk som omfatter antigenisk materiale avledet fra ett eller flere firm-fiskpatogener i assosiasjon med liposomer og som eventuelt inkluderer andre terapeutiske forbindelser. Vaksinene kan anvendes for immunisering og/eller for terapeutisk behandling av firme-fisk mot infeksiøse og parasittiske sykdommer. Vaksinene kan gi reduserte bivirkninger som mindre adhesjoner og pigmentering sammenlignet med oljebaserte vaksineformuleringer. Det besltrives videre fremgangsmåter for fremstilling og lagring av liposomvaksinene og metoder for adminisfrering av vaksineformuleringen til firme-fisk.Liposome vaccine formulations for fish are disclosed which comprise antigenic material derived from one or more company fish pathogens in association with liposomes and which may include other therapeutic compounds. The vaccines can be used for immunization and / or for the therapeutic treatment of firm fish against infectious and parasitic diseases. The vaccines can produce reduced side effects such as minor adhesions and pigmentation compared to oil-based vaccine formulations. Further, methods for preparing and storing the liposome vaccines and methods for administering the vaccine formulation to corporate fish are discussed.

NO20045587A 2002-05-31 2004-12-22 Liposome vaccine comprising antigenic material from fin-fish pathogens. NO335784B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38502802P 2002-05-31 2002-05-31
PCT/CA2003/000768 WO2003101482A2 (en) 2002-05-31 2003-05-30 Liposome vaccine formulations for fin-fish

Publications (2)

Publication Number Publication Date
NO20045587L true NO20045587L (en) 2004-12-22
NO335784B1 NO335784B1 (en) 2015-02-16

Family

ID=29712127

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20045587A NO335784B1 (en) 2002-05-31 2004-12-22 Liposome vaccine comprising antigenic material from fin-fish pathogens.

Country Status (3)

Country Link
AU (1) AU2003229199A1 (en)
NO (1) NO335784B1 (en)
WO (1) WO2003101482A2 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1789554B1 (en) 2004-07-28 2018-07-04 National Research Council Of Canada Recombinant vaccines against caligid copepods (sea lice) and antigen sequences thereof
CN1276076C (en) * 2004-12-14 2006-09-20 华东理工大学 No mark gene deletion deoxidated mutant strain of wild Manhu bacteria and its use
EP1982726A1 (en) * 2006-02-07 2008-10-22 Nippon Biologicals, Inc. Novel vaccine carrier
JP2010514412A (en) 2006-12-22 2010-05-06 ソリューシオネス バイオテクノロジカス イノヴァシオン リミターダ DNA fish vaccine
ES2321789B1 (en) * 2007-03-02 2010-03-15 Instituto Nacional De Investigacion Y Tecnologia Agraria Y Alimentaria (Inia) USE OF THE PIL8 + VECTOR TRUCK AS IMMUNO STIMULANT OR ADJUVANT FOR DNA VACCINES IN FISH.
WO2009070929A1 (en) * 2007-12-04 2009-06-11 Schweitzer Co., Ltd. A subunit vaccine for aquaculture
NO333242B1 (en) * 2008-02-08 2013-04-15 Pharmaq As Composition, medical application and method comprising salmonid alphavirus
CN107099496B (en) * 2017-04-25 2021-04-13 中国农业科学院哈尔滨兽医研究所 Recombinant lactic acid bacteria strain for fusion expression of chicken infectious bursal disease virus VP2 protein and salmonella outer membrane protein and application thereof
NO20200827A1 (en) * 2017-12-26 2020-07-14 Univ Chile Vaccine formulation for fish based on lipid nanovesicles,particularly a proteoliposome or cochleate, with activity against the salmonid rickettsial syndrome (srs)
CN111018955B (en) * 2020-01-06 2021-10-26 济南大学 Polypeptide for inhibiting viral genome RNA replication
KR102458429B1 (en) * 2021-03-18 2022-10-26 대한민국 Fish Oral Vaccine Liposomes for preventing viral hemorrhagic septicemia and Preparation Method Thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1765300A (en) * 1998-12-22 2000-07-12 Dalhousie University Compositions and methods for reducing or preventing fertilization in fish and birds

Also Published As

Publication number Publication date
NO335784B1 (en) 2015-02-16
AU2003229199A1 (en) 2003-12-19
WO2003101482A2 (en) 2003-12-11
WO2003101482A3 (en) 2004-02-05
AU2003229199A8 (en) 2003-12-19

Similar Documents

Publication Publication Date Title
NO20040258L (en) Preparation for the treatment of nail infections with nitric oxide
NO20015073D0 (en) vaccinations
WO2005116270A3 (en) Influenza virus vaccine composition and method of use
NO20045587L (en) Liposome vaccine formulation for finding fish
CY1105221T1 (en) MEDICINAL USE OF THYROIDOMIMETIC COMPOUNDS FOR THE THERAPEUTIC TREATMENT OF HAIR LOSS AND PHARMACEUTICAL COMPOSITIONS
CY1111916T1 (en) VACCINATED VACCINATED ROTAIUS VACCINE FOR ADMINISTRATION OF THE ORAL
NO20055496D0 (en) Pyrazoloquinazoline derivatives, methods for their preparation and their use as kinase inhibitors
CA3030422C (en) Stabilizing excipients for therapeutic protein formulations
HUP0101619A2 (en) Adjuvant compositions
ES2566973T9 (en) Use of SNS-595 to treat leukemia
CY1117237T1 (en) STABLE COMPOSITIONS OF THIACUMYKINS
DK1765289T3 (en) Compositions and Methods for Stabilizing Lipid-Based Adjuvant Formulations Using Glycolipids
CY1117290T1 (en) TREATMENT VACCINE AND METHOD OF USE OF IT
JP2009514840A5 (en)
WO2014205199A3 (en) Compositions and methods for potentiating immune response, enhancing immunotherapy, and increasing vaccine potency
DE60331412D1 (en) HIV vaccine and method of administration
CY1112867T1 (en) SELECTION SHAPES COMING FROM CONTAINER 1 TO VASCULAR GROWTH FACTORS AND VACCINES CONTAINING THESE PEOPLE
CY1120793T1 (en) METHODS OF TREATMENT OF HAIR CONDITIONS
EA200801411A1 (en) NEW ADJUVANTS BASED ON CONJUGATES AND DERIVATIVES OF BIS-ACYLOXYPROPYLCYSTEIN AND THEIR USE IN PHARMACEUTICAL COMPOSITIONS
MX2022006742A (en) Use and pharmaceutical composition of phenylisoxazolyl methylene-naphthalene-ether derivatives.
ATE460943T1 (en) THERAPEUTIC AGENTS AS ANTI-CANCER VACCINE ADJUVANTS AND THERAPEUTIC METHODS
CY1109233T1 (en) PREVENTIVE AND THERAPEUTIC USE OF HYDROXYSTEROIDS
DE60336588D1 (en) IMPROVED ANTHRAXIMP AND METHOD OF DELIVERY
MX344544B (en) Blood stage malaria vaccine.
EA201792237A1 (en) PHARMACEUTICAL COMPOSITIONS

Legal Events

Date Code Title Description
CREP Change of representative

Representative=s name: PLOUGMANN & VINGTOFT POSTBOKS 1003 SENTRUM OSLO, 0

CREP Change of representative

Representative=s name: ONSAGERS AS, POSTBOKS 1813 VIKA, 0123 OSLO, NORGE

MK1K Patent expired